About us

We are a multidisciplinary team of scientists, entrepreneurs and healthcare professionals, working to revolutionise the way people access diagnosis and treatment for major diseases.

Asset 57
Asset 58

We are on a mission to prevent millions of premature deaths by identifying those at highest risk of Cardio, Metabolic and Renal (CMR) diseases.

Currently most people at high risk of disease do not think they are. Even those that take steps to see a Doctor are often turned away due to resource limitations. Without concrete results and guidance, they may be unable to take the necessary steps to improve their long-term health or delay/prevent disease.

Access issues have become even more pronounced as health inequalities have widened. In response, we pondered the question: How can we make it easier for patients to undergo blood tests and facilitate screening?

Our answer was to leverage the ubiquity and image analysis capabilities of smartphones. We designed an accessible test that harnesses the phone’s image analysis capabilities and creates a unique offering combined with cloud computing.

Co-Founders

Steve Roest
Steve Roest
Chief Executive Officer & Co-founder

Steve has 20 years’ experience building high-growth tech businesses, with a personal passion for the cardiovascular disease space. He is CEO of PocDoc, sits on two NHS England advisory boards, is a UKRI Fellow and hosts HealthTech Hour, which is one of the world’s largest healthtech podcasts.

Kiran Roest
Dr Kiran Roest
Chief Strategy Officer & Co-founder

Kiran co-founded PocDoc and owns clinical and regulatory strategy, including PocDoc’s extensive peer-reviewed evidence base. Before PocDoc she spent over a decade in pharma commercial strategy and business development, including at Pfizer. She holds a PhD from Imperial College London and a first-class Natural Sciences degree from Cambridge.

Vladimir Gubala
Dr Vladimir Gubala
Chief Scientific Officer & Co-founder

Vlad is one of the most highly cited academics in personalised diagnostics, with more than 50 peer-reviewed papers and 4,000 citations. Vlad is widely regarded as one of the leading authority on microfluidics and digital diagnostics. After completing his PhD in 2006, he worked at the University of Florida, later joining the world of point-of-care diagnostics at the Biomedical Diagnostics Institute.

Kate Bunyan
Dr Kate Bunyan, MBBS, MSc
Medical Director

Kate is a physician and clinical executive. She was formerly CMO and Chief Clinical Innovation Officer at Doctor Care Anywhere, where she scaled the service tenfold through COVID-19 and launched two product lines, and was previously Medical Director at Carnival UK. At PocDoc she leads clinical strategy, governance, and regulatory compliance.

Prakash Shah
Prakash Shah
Chief Financial Officer

Prakash is PocDoc’s CFO, an ACA-trained finance leader who trained at Deloitte and operated in roles at JPMorgan and M&G. In recent years, he has been CFO to high-growth healthtech and diagnostics companies - including uMotif, Lucida Medical and Digistain - giving him a deep understanding of the economics of funding a diagnostic and bringing it to market. His track record spans equity and debt fundraising. He also co-founded the Startup CFO UK network.

Robin Matthews
Robin Matthews
Chief Technology Officer

Robin is a battle-scarred product and technology leader who has championed Agentic AI within healthcare from day one. He is a thought leader on Agentic AI in health, with a track record of building at scale. Over the last decade, he has operated in product and technology leadership roles, creating over $2 billion in equity value.

Dal Bamford
Dal Bamford
Chief Revenue Officer

Dal is a commercial leader with over 25 years of experience scaling technology businesses, from global platforms including Salesforce to early-stage ventures backed by some of Europe’s leading investors. At PocDoc she leads go-to-market strategy, the B2B pipeline and partner engagement across Public Health, Private Health, and Consumer.

Martin Frost
Martin Frost, CBE
Chair

Martin is a serial co-founder, chair and advisor across life and physical sciences. He is best known for founding CMR Surgical in 2014 and leading it as CEO to 2020, through the global launch of its Versius surgical robot - raising over £250m (a record fora private European medtech) and building the company towards a c.£3bn valuation. He was formerly CEO and CFO of Sagentia (now Science Group). Martin was voted EY Entrepreneur of the Year in 2019 and Cambridge Independent CEO of the Year in 2018, and was awarded a CBE in 2020 for services to robotics and British industry.

Get in touch to find out more

Contact us Careers

Depositphotos 30462227 L lq